SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005903
Filing Date
2021-05-05
Accepted
2021-05-05 16:02:53
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20210331x10q.htm   iXBRL 10-Q 2059984
2 EX-10.1 rigl-20210331xex10d1.htm EX-10.1 980303
3 EX-10.2 rigl-20210331xex10d2.htm EX-10.2 25617
4 EX-31.1 rigl-20210331xex31d1.htm EX-31.1 16314
5 EX-31.2 rigl-20210331xex31d2.htm EX-31.2 16965
6 EX-32.1 rigl-20210331xex32d1.htm EX-32.1 8795
7 GRAPHIC rigl-20210331x10q004.jpg GRAPHIC 73022
  Complete submission text file 0001558370-21-005903.txt   8764640

Data Files

Seq Description Document Type Size
8 EX-101.SCH rigl-20210331.xsd EX-101.SCH 54183
9 EX-101.CAL rigl-20210331_cal.xml EX-101.CAL 51092
10 EX-101.DEF rigl-20210331_def.xml EX-101.DEF 177332
11 EX-101.LAB rigl-20210331_lab.xml EX-101.LAB 482158
12 EX-101.PRE rigl-20210331_pre.xml EX-101.PRE 335013
13 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20210331x10q_htm.xml XML 1267948
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 21893129
SIC: 2834 Pharmaceutical Preparations